Download Files:
Products Details
Product Description
– DCZ19931 is a potent multi-targeting kinase inhibitor. DCZ19931 has anti-angiogenic effects on ocular neovascularization. DCZ19931 also inhibits ERK1/2-MAPK and p38-MAPK signaling[1].
Web ID
– HY-152087
Shipping
– Room temperature
Molecular Formula
– C26H20F5N3O5
References
– [1]Zhang H, et al. DCZ19931, a novel multi-targeting kinase inhibitor, inhibits ocular neovascularization. Sci Rep. 2022 Dec 13;12(1):21539.
CAS Number
– 2789629-84-9
Molecular Weight
– 549.45
SMILES
– COC1=CC(NC(C(F)(C2=CC=C(C=C2)OC3=C4C=C(C(OC)=CC4=NC=N3)OC)F)=O)=CC(C(F)(F)F)=C1
Clinical Information
– No Development Reported
Research Area
– Cardiovascular Disease
Solubility
– 10 mM in DMSO
Target
– ERK;p38 MAPK
Isoform
– ERK1;ERK2;p38 MAPK
Pathway
– MAPK/ERK Pathway;Stem Cell/Wnt
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
